Award
Delivery Order #SPE2DR26FHBR9
Delivery Order for NEXPLANON Implants Under Pharmaceutical Provision IDV
Buyer
Defense Logistics Agency
Award Amount
$33,525.60
Ceiling
$33,525.60
Awarded
March 11, 2026
Period of Performance
Mar 11, 2026 – Apr 01, 2026
Identifier
SPE2DR26FHBR9
NAICS
424210
This award represents a delivery order contract issued to DMS Pharmaceutical Group Inc., a company specializing in pharmaceutical logistics and distribution. It involves the procurement of NEXPLANON 68 mg implants, a hormonal contraceptive device, for government healthcare programs. The delivery order is part of a larger indefinite delivery vehicle (IDV) contract focused on pharmaceutical provisions, emphasizing a multi-year effort to supply essential healthcare products. The significance of this contract lies in ensuring the availability of critical medications that support public health initiatives. The scope of work includes the timely delivery of these medical implants to a specified location in Park Ridge, Illinois, over a short-term period in early 2026. This award followed the framework established by the overarching IDV, representing a methodical and efficient approach to meeting specific pharmaceutical needs. The contract was competitively awarded within the structure of the existing IDV. No additional subcontractor or previous contract details were provided.
Description
4571130996!NEXPLANON 68 MG IMPLANTS